Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Brainsway Ltd.BWAY · Entity 5378 | Chief Technology Officer | May 25, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Brainsway Ltd.
Report date May 25, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 53,098 |
Last balance in matching sequence
After 2026-06-15 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-05-25 · Exercise / conversion · Acquired 7,500 · Balance 60,000 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2: The exercise price is NIS 11.17 per share. F3: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. Row 2 · 2026-05-25 · Tax withholding · Disposed 1,902 · Balance 58,098 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4: These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person. F3: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. Row 3 · 2026-06-15 · Sale · Disposed 5,000 · Balance 53,098 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5: The sale price was NIS 42.0397 per share. F3: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Expires 2034-03-05 | Direct | 22,500 |
Reported balance
After 2026-05-25 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-25 · Exercise / conversion · Disposed 7,500 · Balance 22,500 F2: The exercise price is NIS 11.17 per share. F6: Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028. F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2: The exercise price is NIS 11.17 per share.
F3: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.
F4: These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person.
F5: The sale price was NIS 42.0397 per share.
F6: Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 22, 2026 20:04 UTC | Brainsway Ltd. BWAY · Entity 5378 | SaleOrdinary Shares | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001171843-26-004216 · ownership.xml · nonDerivative · entry 3 Moiseyev Gilad · CIK 0002111634 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,098 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The sale price was NIS 42.0397 per share. F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. Read SEC document |
| May 25, 2026 Filed Jun 22, 2026 20:04 UTC | Brainsway Ltd. BWAY · Entity 5378 | Exercise / conversionStock Options (right to buy) · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-26-004216 · ownership.xml · derivative · entry 4 Moiseyev Gilad · CIK 0002111634 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Ordinary Shares · 7,500 shares Expires 2034-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price is NIS 11.17 per share. F6 · derivative.exercise_date: Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| May 25, 2026 Filed Jun 22, 2026 20:04 UTC | Brainsway Ltd. BWAY · Entity 5378 | Tax withholdingOrdinary Shares | 1,902 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001171843-26-004216 · ownership.xml · nonDerivative · entry 2 Moiseyev Gilad · CIK 0002111634 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,098 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person. F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. Read SEC document |
| May 25, 2026 Filed Jun 22, 2026 20:04 UTC | Brainsway Ltd. BWAY · Entity 5378 | Exercise / conversionOrdinary Shares | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001171843-26-004216 · ownership.xml · nonDerivative · entry 1 Moiseyev Gilad · CIK 0002111634 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price is NIS 11.17 per share. F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.